
Eli Lilly and Co. (NYSE:LLY) announced on Tuesday that it plans to build a $5 billion manufacturing facility just west of Richmond, Virginia, in Goochland County.
The new facility will be Eli Lilly’s first fully integrated site dedicated to both active pharmaceutical ingredient (API) production and drug products, supporting its growing bioconjugate platform and monoclonal antibody portfolio.